Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk.
The renin-angiotensin system (RAS), besides being a major regulator of blood pressure, is also involved in tumor angiogenesis. Emerging evidence suggests a correlation between the use of pharmacologic RAS inhibitors and a delay in urothelial bladder cancer (BC) progression. However, it is unknown wh...
| Published in: | Current Oncology Vol. 28; no. 6; pp. 4702 - 4709 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
MDPI
Dec2021
|
| Online Access: | View this record in EBSCOhost |